NCT00413764View on ClinicalTrials.gov

Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

PHASE3CompletedINTERVENTIONAL

Enrollment

358

Participants

Timeline

Start Date

March 23, 2004

Primary Completion Date

November 15, 2005

Study Completion Date

November 15, 2005

Conditions

Sexual Dysfunction

Interventions

DRUG

tibolone

tibolone (2.5 mg) over 24 weeks

DRUG

estradiol-norethisterone

transdermal continuous combined E2-NETA (estradiol-norethisterone 50/140 mcg) over 24 weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00413764 - Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089) | Biotech Hunter | Biotech Hunter